Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 5 million patients benefit from Medtronic's technology, used to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses.
710 Medtronic Pkwy
Minneapolis, MN 55432-5604
News | Cardiac Resynchronization Therapy Devices (CRT) | March 17, 2016
Medtronic plc announced that it received CE (Conformité Européenne) Mark for the first and only cardiac...
News | Heart Valve Technology | March 07, 2016
Medtronic plc announced the first patients enrolled in the Evolut R FORWARD Clinical Study to evaluate performance...
News | Heart Valve Technology | February 23, 2016
The U.S. Food and Drug Administration (FDA) approved an expanded indication trial for low-risk surgical patients using...
Feature | Peripheral Artery Disease (PAD) | February 22, 2016 | Dave Fornell
It is estimated that more than 10 million people in the United States are affected by...
News | February 03, 2016 | Dave Fornell
Medtronic announced Feb. 3 that the U.S.
News | Stents Drug Eluting | February 02, 2016
Medtronic plc announced the recent CE Mark and commercial launch for an expanded size matrix of the Resolute Onyx DES,...
News | Drug-Eluting Balloons | January 18, 2016
Medtronic plc announced that the IN.PACT Admiral drug eluting balloon (DEB) has received CE (Conformité Européene) Mark...
Feature | Heart Valve Technology | January 15, 2016 | Dave Fornell
January 15, 2016 — The U.S.
Feature | Heart Valve Technology | November 12, 2015 | Dave Fornell
(This article was updated in June 2018)
News | Pacemakers | November 11, 2015
Medtronic plc announced that the Medtronic Micra Transcatheter Pacing System (TPS) was successfully implanted in...